Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

42 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Anal Cancer NCT00324415 Response - AMC-045 Response Assessment Forms (RA1; RA2) - 2514651v1.0 - Response Assessment Forms (RA1; RA2 AMC-045)

- 12.03.15 - 1 Formular, 5 Itemgruppen, 21 Datenelemente, 1 Sprache
Itemgruppen: Header, Target Lesions (RA1), Nontarget Lesions (RA1), Response Assessment Form (RA2), Comments
Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer NCT00324415 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1BB34737-57FC-61F2-E044-0003BA3F9857

Anal Cancer NCT00324415 Treatment - AMC-045 Study Drug Therapy Form (SDT) - 2514584v1.0 - AMC-045 Study Drug Therapy Form (SDT)

- 09.01.15 - 1 Formular, 3 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Header Module, Cycle and Dose Modification, Comments
AMC-045 Study Drug Therapy Form (SDT) Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1BB1575F-CA34-29C3-E044-0003BA3F9857

Anal Cancer NCT00324415 On-Study - AMC-045 History of AIDS Defining Disease Form (F03) - 2937261v1.0 - History of AIDS Defining Disease Form (F03, AMC-045 NCT00324415 )

- 14.03.15 - 1 Formular, 2 Itemgruppen, 6 Datenelemente, 1 Sprache
Itemgruppen: Header Module, History of AIDS Defining Disease
Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer NCT00324415 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=72873427-47DC-3052-E040-BB89AD43686C

Anal Cancer NCT00324415 Toxicity - AMC-045 Type III Adverse Event Reporting Form (TAE) - 2516535v1.0 - AMC-045 Type III Adverse Event Reporting Form (TAE)

- 13.04.21 - 1 Formular, 3 Itemgruppen, 7 Datenelemente, 1 Sprache
Itemgruppen: Administrative, Severe Adverse Event (Grade 3), Comments
AMC-045 Type III Adverse Event Reporting Form (TAE) Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1C146B28-823F-583B-E044-0003BA3F9857

Anal Cancer NCT00550589 Off Treatment - AMC-046 Off-Protocol Treatment Summary Form (F05) - 2989512v1.0 - AMC-046 Off-Protocol Treatment Summary Form (F05)

- 08.01.15 - 1 Formular, 1 Itemgruppe, 4 Datenelemente, 1 Sprache
Itemgruppe: Off-Protocol Treatment Summary
AMC-046 Off-Protocol Treatment Summary Form (F05) Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7D8985E5-2F13-08A5-E040-BB89AD434A3B

Anal Cancer NCT00324415 Off Treatment - AMC-045 Off Protocol Treatment Summary Form (F05) - 2936946v1.0 - AMC-045 Off Protocol Treatment Summary Form (F05)

- 08.01.15 - 1 Formular, 1 Itemgruppe, 4 Datenelemente, 1 Sprache
Itemgruppe: Off-Protocol Treatment Summary
AMC-045 Off Protocol Treatment Summary Form (F05) Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7284A0F2-BE44-FDEC-E040-BB89AD43537B

HIV Cidovir High-Grade Squamous Intraepithelial Lesions NCT00550589 AMC-046 - Off-Study Summary Form (F50)

- 09.06.17 - 1 Formular, 1 Itemgruppe, 4 Datenelemente, 1 Sprache
Itemgruppe: Off-Study Summary
AMC-046 Off-Study Summary Form (F50) Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus https://clinicaltrials.gov/ct2/show/NCT00550589

HIV Cidofovir AMC-046 NCT00550589 - HIV T-Cell Laboratory Values (F24)

- 09.06.17 - 1 Formular, 4 Itemgruppen, 11 Datenelemente, 2 Sprachen
Itemgruppen: Header Module, Date of Evaluation, T-Cell Laboratory Values, Comments
AMC-046 HIV T-Cell Laboratory Values (F24) Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus https://clinicaltrials.gov/ct2/show/NCT00550589

AMC-045 Off Study Summary Form (F50)

- 24.05.17 - 1 Formular, 1 Itemgruppe, 4 Datenelemente, 1 Sprache
Itemgruppe: Off-Study Summary
AMC-045 Off Study Summary Form (F50) Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7284A0F2-BE74-FDEC-E040-BB89AD43537B

AMC-076 Dysplasia Treatment Form (DYS) NCT01164722

- 08.07.15 - 1 Formular, 3 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Header Module, Dysplasia Treatment, Comments
AMC-076 Dysplasia Treatment Form (DYS) NCT01164722 Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A8216D81-B789-F026-E040-BB89AD436DD3

AMC-045 Complete Physical Exam Form (F21) NCT00324415

- 08.07.15 - 1 Formular, 3 Itemgruppen, 7 Datenelemente, 1 Sprache
Itemgruppen: Header module, Physical Exam, Comments
AMC-045 Complete Physical Exam Form (F21) NCT00324415 Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4428A103-FC35-0EB3-E044-0003BA3F9857

Eligibility Carcinoma of the Anal Canal NCT01858025

- 13.10.19 - 1 Formular, 2 Itemgruppen, 12 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01858025

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video